| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |